Skip to main content
. 2022 Apr 15;58:22–31. doi: 10.1016/j.arbres.2022.03.010

Table 3.

Demographic and clinical characteristics of patients with COVID-19 admitted to Spanish ICUs.

All patients, n 6102
Age (years) 63 [54-71]
Sex (male) 4290 (70.3)
BMI 28.8 [26.0-32.3]
Comorbidities (No. with data)
 Hypertension 3075 (50.4)
 Diabetes mellitus 1507 (24.7)
 Chronic cardiovascular disease 793 (13.0)
 Chronic pulmonary disease 622 (10.2)
 Chronic kidney disease 439 (7.2)
Disease chronology from symptoms onset
 To hospital admission (days) 7 [5-9]
 To ICU admission (days) 9 [7-12]
 To IMV start (days) 10 [7-13]
Symptoms at hospital admission
 Fever 5123 (82.9)
 Dry cough 3740 (61.3)
 Productive cough 790 (12.9)
 Shortness of breath 4432 (72.6)
 Anosmia 442 (7.2)
 Headache 834 (13.7)
 Myalgia 1646 (27.0)
 Diarrhea 1320 (21.6)
Severity scores at ICU admission
 SOFA 5 [4-7]
 APACHE II 12 [9-16]
Vital signs at ICU admission
 Temperature (°C) 36.8 [36.0-37.5]
 Mean arterial pressure (mmHg) 88 [75-100]
 Respiratory rate (bpm) 25 [21-31]
Blood gases and laboratory parameters at ICU admission
 PaO2/FiO2 (mmHg) 112.5 [80.6-163.3]
 PaCO2 (mmHg) 39.0 [34.0-47.0]
 pH 7.41 [7.34-7.46]
 Lymphocyte count (×109/L) 0.69 [0.47-0.99]
 D-dimer (ng/mL) 1000.0 [518.0-2334.75]
 C-reactive protein (mg/L) 128.0 [61.5-220.0]
 Ferritin (pg/mL) 1142.0 [605.7-1880.3]
 IL-6 (pg/mL) 86.6 [31.6-222.3]
Interventions
 IMV 4638 (76.0)
 Prone position 3667 (60.1)
 Tracheostomy 1812 (29.7)
 ECMO 164 (2.7)
 Renal replacement therapy 549 (9.7)
Complications
 ARDS 4792 (78.6)
 Bacterial pneumonia 1861 (30.5)
 Pulmonary embolism 568 (9.3)
 Coagulation disorder 1458 (23.9)
 Acute renal injury 1953 (32.0)
 Liver disfunction 1825 (29.9)
Outcomes
 ICU length (days) 13 [7-27]
 IMV length (days) 15 [8-27]
 Hospital length (days) 23 [14-40]
 In-hospital mortality 1911 (31.4)

APACHE-II: Acute Physiology and Chronic Health Evaluation; ARDS: acute respiratory distress syndrome; BMI: body mass index; ECMO: extracorporeal membrane oxygenation; ICU: intensive care unit; IL-6: interleukin-6; IMV: invasive mechanical ventilation; SOFA: Sequential Organ Failure Assessment.

Data are expressed as n (%) or median [interquartile range].